Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02382003 · ClinicalTrials.gov registry record · Phase 2
Web-based Interpretation Training For Anxiety
A Phase 2 study, sponsored by University of Virginia.
- Completed
- Registry status
- Phase 2
- Development phase
- 807
- Enrollment target
NCT02382003: Completed Phase 2 study, sponsored by University of Virginia.
NCT02382003 is a Phase 2 study that has completed, run by University of Virginia. The registered enrollment target is 807 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (507% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02382003, a Phase 2 study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 807 participants
- Enrollment target
Study Summary
The study aims to develop a web-based Cognitive Bias Modification infrastructure to train interpretations, and evaluate the usability, acceptability, and feasibility of the program to reduce anxiety symptoms.
Primary Outcome
To measure interpretation bias, participants will read ambiguous scenarios with titles, after which they will see the titles of each scenario, followed by 2 disambiguated interpretations of the scenario: 1 positive and 1 negative. Participants will rate each disambiguated interpretation based on how similar in meaning it is to the original scenario on a 4-point scale ranging from 1 to 4. The mean of the positive, threat-related ratings index positive interpretation bias. Higher scores represent
Interventions
- BEHAVIORAL Positive Cognitive Bias Modification - Interpretation
- BEHAVIORAL 50/50 Cognitive Bias Modification - Interpretation
- BEHAVIORAL Anxious Imagery Prime
- BEHAVIORAL Neutral Imagery Prime
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 807 participants |
| Start Date | 2016-04 |
| Est. Completion | 2019-03 |
| Phase | Phase 2 |
What the finished NCT02382003 record still lists
NCT02382003 is an interventional study that assigns participants to a tested intervention. The registered 807 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (507% higher).
The record links to 0 conditions, and to 4 interventions - of which Positive Cognitive Bias Modification - Interpretation is the first listed.
NCT02382003 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02382003 about?
NCT02382003 is a clinical study titled "Web-based Interpretation Training For Anxiety". The study aims to develop a web-based Cognitive Bias Modification infrastructure to train interpretations, and evaluate the usability, acceptability, and feasibility of the program to reduce anxiety symptoms.
What is the current status of trial NCT02382003?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 807 participants. The study started on 2016-04. Estimated completion is 2019-03.
What interventions are being tested in trial NCT02382003?
The interventions under investigation include: Positive Cognitive Bias Modification - Interpretation (BEHAVIORAL), 50/50 Cognitive Bias Modification - Interpretation (BEHAVIORAL), Anxious Imagery Prime (BEHAVIORAL), Neutral Imagery Prime (BEHAVIORAL).
Who is sponsoring clinical trial NCT02382003?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02382003's enrollment target sits among peer trials
807 36th of 2000 higher than 1,965 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06529094 · 808 participants · NA
Implementing a Decision Support Tool to Prevent Community-Acquired Pressure Injury in Spinal Cord Injury (SCI) in the Spinal Cord Injury Clinic
- NCT04613596 · 806 participants · Phase 2
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
- NCT06065098 · 806 participants · NA
Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health
- NCT05519085 · 810 participants · Phase 3
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia